The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease

Infection and Immunity

Volumn 78, Issue 7, 2010, Pages 3177-3186

  Fransen, Floris ^a,b   Hamstra, Hendrik Jan ^a   Boog, Claire J ^a,b   Van Putten, Jos P ^b   Van Den Dobbelsteen, Germie P J M ^a   Van Der Ley, Peter ^a  

^a NETHERLANDS VACCINE INSTITUTE   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID A; RANTES; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CYTOKINE PRODUCTION; FEMALE; INNATE IMMUNITY; MENINGOCOCCEMIA; MENINGOCOCCOSIS; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTEREMIA; BACTERIAL OUTER MEMBRANE PROTEINS; CELL LINE; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY, INNATE; LIPID A; MENINGOCOCCAL INFECTIONS; MICE; MICE, INBRED C57BL; MUTATION; NEISSERIA MENINGITIDIS; TOLL-LIKE RECEPTOR 4;

EID: 77953926107     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01311-09     Document Type: Article

References (56)

1. Akashi, S., Y. Nagai, H. Ogata, M. Oikawa, K. Fukase, S. Kusumoto, K. Kawasaki, M. Nishijima, S. Hayashi, M. Kimoto, and K. Miyake. 2001. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int. Immunol. 13:1595-1599.
2. An, H., H. Xu, Y. Yu, M. Zhang, R. Qi, X. Yan, S. Liu, W. Wang, Z. Guo, Z. Qin, and X. Cao. 2002. Up-regulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-kappaB, ERK and p38 MAPK signal pathways. Immunol. Lett. 81:165-169.
3. Banus, H. A., R. J. Vandebriel, R. H. de, J. A. Dormans, N. J. Nagelkerke, F. R. Mooi, B. Hoebee, H. J. van Kranen, and T. G. Kimman. 2006. Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology. Infect. Immun. 74:2596-2605.
4. Bergman, P., L. Johansson, H. Wan, A. Jones, R. L. Gallo, G. H. Gudmundsson, T. Hokfelt, A. B. Jonsson, and B. Agerberth. 2006. Induction of the antimicrobial peptide CRAMP in the blood-brain barrier and meninges after meningococcal infection. Infect. Immun. 74:6982-6991.
5. Bernheiden, M., J. M. Heinrich, G. Minigo, C. Schutt, F. Stelter, M. Freeman, D. Golenbock, and R. S. Jack. 2001. LBP, CD14, TLR4 and the murine innate immune response to a peritoneal Salmonella infection. J. Endotoxin Res. 7:447-450.
6. Beutler, B., and E. T. Rietschel. 2003. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3:169-176.
7. Brandtzaeg, P., K. Bryn, P. Kierulf, R. Ovstebo, E. Namork, B. Aase, and E. Jantzen. 1992. Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J. Clin. Invest. 89:816-823.
8. Brandtzaeg, P., P. Kierulf, P. Gaustad, A. Skulberg, J. N. Bruun, S. Halvorsen, and E. Sorensen. 1989. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infect. Dis. 159:195-204.
9. Bukholm, G., B. P. Berdal, C. Haug, and M. Degre. 1984. Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice. Infect. Immun. 45:62-66.
10. Copeland, S., H. S. Warren, S. F. Lowry, S. E. Calvano, and D. Remick. 2005. Acute inflammatory response to endotoxin in mice and humans. Clin. Diagn. Lab. Immunol. 12:60-67.
11. Darton, T., M. Guiver, S. Naylor, D. L. Jack, E. B. Kaczmarski, R. Borrow, and R. C. Read. 2009. Severity of meningococcal disease associated with genomic bacterial load. Clin. Infect. Dis. 48:587-594.
12. Dixon, D. R., and R. P. Darveau. 2005. Lipopolysaccharide heterogeneity: innate host responses to bacterial modification of lipid A structure. J. Dent. Res. 84:584-595.
13. Ernst, R. K., K. N. Adams, S. M. Moskowitz, G. M. Kraig, K. Kawasaki, C. M. Stead, M. S. Trent, and S. I. Miller. 2006. The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway. J. Bacteriol. 188:191-201.
14. Ernst, R. K., E. C. Yi, L. Guo, K. B. Lim, J. L. Burns, M. Hackett, and S. I. Miller. 1999. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286:1561-1565.
15. Faber, J., N. Henninger, A. Finn, W. Zenz, F. Zepp, and M. Knuf. 2009. A Toll-like receptor 4 variant is associated with fatal outcome in children with invasive meningococcal disease. Acta Paediatr. 98:548-552.
16. Faber, J., C. U. Meyer, C. Gemmer, A. Russo, A. Finn, C. Murdoch, W. Zenz, C. Mannhalter, B. U. Zabel, H. J. Schmitt, P. Habermehl, F. Zepp, and M. Knuf. 2006. Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy. Pediatr. Infect. Dis. J. 25:80-81.
17. Fransen, F., S. G. Heckenberg, H. J. Hamstra, M. Feller, C. J. Boog, J. P. van Putten, D. van de Beek, A. van der Ende, and P. van der Ley. 2009. Naturally occurring lipid A mutants in Neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS. Pathog. 5:e1000396.
18. Gioannini, T. L., and J. P. Weiss. 2007. Regulation of interactions of Gramnegative bacterial endotoxins with mammalian cells. Immunol. Res. 39:249-260.
19. Gorringe, A. R., K. M. Reddin, S. G. Funnell, L. Johansson, A. Rytkonen, and A. B. Jonsson. 2005. Experimental disease models for the assessment of meningococcal vaccines. Vaccine 23:2214-2217. (Pubitemid 40341454)
20. Guo, L., K. B. Lim, J. S. Gunn, B. Bainbridge, R. P. Darveau, M. Hackett, and S. I. Miller. 1997. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276:250-253.
21. Hackett, S. J., A. P. Thomson, and C. A. Hart. 2001. Cytokines, chemokines and other effector molecules involved in meningococcal disease. J. Med. Microbiol. 50:847-859.
22. Hajjar, A. M., R. K. Ernst, J. H. Tsai, C. B. Wilson, and S. I. Miller. 2002. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3:354-359.
23. Kahler, C. M., and D. S. Stephens. 1998. Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin). Crit. Rev. Microbiol. 24:281-334.
24. Kawasaki, K., R. K. Ernst, and S. I. Miller. 2004. 3-O-deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through Toll-like receptor 4. J. Biol. Chem. 279:20044-20048.
25. Kawasaki, K., R. K. Ernst, and S. I. Miller. 2004. Deacylation and palmitoylation of lipid A by Salmonellae outer membrane enzymes modulate host signaling through Toll-like receptor 4. J. Endotoxin Res. 10:439-444.
26. Khan, S. A., P. Everest, S. Servos, N. Foxwell, U. Zahringer, H. Brade, E. T. Rietschel, G. Dougan, I. G. Charles, and D. J. Maskell. 1998. A lethal role for lipid A in Salmonella infections. Mol. Microbiol. 29:571-579.
27. Lien, E., T. K. Means, H. Heine, A. Yoshimura, S. Kusumoto, K. Fukase, M. J. Fenton, M. Oikawa, N. Qureshi, B. Monks, R. W. Finberg, R. R. Ingalls, and D. T. Golenbock. 2000. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105:497-504.
28. Miller, S. I., R. K. Ernst, and M. W. Bader. 2005. LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 3:36-46.
29. Mogensen, T. H., S. R. Paludan, M. Kilian, and L. Ostergaard. 2006. Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J. Leukoc. Biol. 80:267-277.
30. Montminy, S. W., N. Khan, S. McGrath, M. J. Walkowicz, F. Sharp, J. E. Conlon, K. Fukase, S. Kusumoto, C. Sweet, K. Miyake, S. Akira, R. J. Cotter, J. D. Goguen, and E. Lien. 2006. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat. Immunol. 7:1066-1073.
31. Munford, R. S. 2008. Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant? Infect. Immun. 76:454-465.
32. Nicholson, A., and I. H. Lepow. 1979. Host defense against Neisseria meningitidis requires a complement-dependent bactericidal activity. Science 205:298-299.
33. Palsson-McDermott, E. M., and L. A. O'Neill. 2004. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113:153-162. (Pubitemid 39312442)
34. Plant, L., H. Wan, and A. B. Jonsson. 2007. Non-lipooligosaccharide- mediated signalling via Toll-like receptor 4 causes fatal meningococcal sepsis in a mouse model. Cell. Microbiol. 9:657-669.
35. Poltorak, A., P. Ricciardi-Castagnoli, S. Citterio, and B. Beutler. 2000. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc. Natl. Acad. Sci. U. S. A. 97:2163-2167.
36. Schmitt, C., A. Villwock, and O. Kurzai. 2009. Recognition of meningococcal molecular patterns by innate immune receptors. Int. J. Med. Microbiol. 299:9-20.
37. Schneider, M. C., R. M. Exley, S. Ram, R. B. Sim, and C. M. Tang. 2007. Interactions between Neisseria meningitidis and the complement system. Trends Microbiol. 15:233-240.
38. Schromm, A. B., K. Brandenburg, H. Loppnow, A. P. Moran, M. H. Koch, E. T. Rietschel, and U. Seydel. 2000. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur. J. Biochem. 267:2008-2013.
39. Schromm, A. B., K. Brandenburg, H. Loppnow, U. Zahringer, E. T. Rietschel, S. F. Carroll, M. H. Koch, S. Kusumoto, and U. Seydel. 1998. The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity. J. Immunol. 161:5464-5471.
40. Schurr, J. R., E. Young, P. Byrne, C. Steele, J. E. Shellito, and J. K. Kolls. 2005. Central role of Toll-like receptor 4 signaling and host defense in experimental pneumonia caused by gram-negative bacteria. Infect. Immun. 73:532-545.
41. Sjolinder, H., T. H. Mogensen, M. Kilian, A. B. Jonsson, and S. R. Paludan. 2008. Important role for Toll-like receptor 9 in host defense against meningococcal sepsis. Infect. Immun. 76:5421-5428.
42. Smirnova, I., N. Mann, A. Dols, H. H. Derkx, M. L. Hibberd, M. Levin, and B. Beutler. 2003. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc. Natl. Acad. Sci. U. S. A. 100:6075-6080.
43. Somerville, J. E., Jr., L. Cassiano, and R. P. Darveau. 1999. Escherichia coli msbB gene as a virulence factor and a therapeutic target. Infect. Immun. 67:6583-6590.
44. Steeghs, L., R. den Hartog, A. den Boer, B. Zomer, P. Roholl, and P. van der Ley. 1998. Meningitis bacterium is viable without endotoxin. Nature 392:449-450. (Pubitemid 28168969)
45. Steeghs, L., A. M. Keestra, A. van Mourik, H. Uronen-Hansson, P. van der Ley, R. Callard, N. Klein, and J. P. van Putten. 2008. Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis. Infect. Immun. 76:3801-3807.
46. Stephens, D. S., B. Greenwood, and P. Brandtzaeg. 2007. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369:2196-2210.
47. Supajatura, V., H. Ushio, A. Nakao, K. Okumura, C. Ra, and H. Ogawa. 2001. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J. Immunol. 167:2250-2256. (Pubitemid 32747537)
48. Tzeng, Y. L., K. D. Ambrose, S. Zughaier, X. Zhou, Y. K. Miller, W. M. Shafer, and D. S. Stephens. 2005. Cationic antimicrobial peptide resistance in Neisseria meningitidis. J. Bacteriol. 187:5387-5396.
49. van der Ley, P., J. E. Heckels, M. Virji, P. Hoogerhout, and J. T. Poolman. 1991. Topology of outer membrane porins in pathogenic Neisseria spp. Infect. Immun. 59:2963-2971.
50. van der Ley, P., L. Steeghs, H. J. Hamstra, J. ten Hove, B. Zomer, and L. van Alphen. 2001. Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. Infect. Immun. 69:5981-5990.
51. van Deuren, M., P. Brandtzaeg, and J. W. van der Meer. 2000. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin. Microbiol. Rev. 13:144-166, table.
52. Waage, A., A. Halstensen, R. Shalaby, P. Brandtzaeg, P. Kierulf, and T. Espevik. 1989. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J. Exp. Med. 170:1859-1867.
53. Westphal, O., and J. K. Jann. 1965. Bacterial lipopolysaccharides extraction with phenol-water and further application of the procedure. Methods Carbohydr. Chem. 5:83-91.
54. Wieland, C. W., S. Florquin, N. A. Maris, K. Hoebe, B. Beutler, K. Takeda, S. Akira, and T. van der Poll. 2005. The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable Haemophilus influenzae from the mouse lung. J. Immunol. 175:6042-6049.
55. Wolfe, D. N., A. M. Buboltz, and E. T. Harvill. 2009. Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity. PLoS One 4:e4280.
56. Woods, J. P., J. A. Frelinger, G. Warrack, and J. G. Cannon. 1988. Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection. Infect. Immun. 56:1950-1955.